Pain News and Research

Latest Pain News and Research

PTSD occurs with significant frequency in civilian patients after traumatic event involving physical injury

Although most commonly associated with military combat, post-traumatic stress disorder (PTSD) can occur in civilians, too - and with consequences that are just as serious, according to a new review article in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS). PTSD is a type of anxiety disorder that occurs after a person experiences a traumatic event involving physical injury, and occurs in 20 to 51 percent of patients with an orthopaedic injury.

9 May 2011

Massachusetts patients face long wait times for doctor appointments

A survey conducted by the Massachusetts Medical Society found patients can wait as a long as a month and a half for non-urgent physicians' appointments.

9 May 2011

Covidien completes enrollment in Parietex ProGrip self-fixating mesh study to treat inguinal hernias

Covidien, a leading global provider of healthcare products, today announced that all 600 patients have been enrolled in its clinical study comparing use of Parietex ProGrip self-fixating mesh to the gold-standard suture-based Lichtenstein repair method for primary inguinal hernias.

9 May 2011

Ideal psychotropic drug may cause physical dependence

A report in the current issue of Psychotherapy and Psychosomatics by a group of European investigators headed by Fabrizio Schifano has explored the potential for dependence of pregabalin using patients' online reports.

9 May 2011

Parasites in human waste fertilizers alarm health experts

It has been suggested that human faeces used as fertiliser on farms are leading to the spread of ‘Third World’ parasites causing a serious stomach illness across Sydney.

8 May 2011

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

iPads help minimize children's pain during procedures

Nurses in the emergency department at NewYork-Presbyterian/Morgan Stanley Children's Hospital are pioneering techniques -- including the use of iPads -- to improve the patient experience by eliminating or minimizing pain.

7 May 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

On Thursday, the U.S. Food and Drug Administration approved Afinitor (everolimus) to treat patients with progressive neuroendocrine tumors located in the pancreas (PNET) that cannot be removed by surgery or that have spread to other parts of the body (metastatic).

7 May 2011

Tufts Health Plan now covers SBi's STAR total ankle replacement system

Small Bone Innovations, Inc. (SBi) announced today that effective July 1, 2011, Tufts Health Plan, covering approximately 742,000 members in Massachusetts and Rhode Island, is revising its reimbursement policy to cover SBi's STAR™ total ankle replacement system. The decision means that 98 percent of all privately-insured lives in Massachusetts will have access to total ankle replacement.

7 May 2011

Burning mouth syndrome affects menopausal women seven times more often than men

Most people can relate to the uncomfortable feeling that occurs after scalding their mouth on hot soup or coffee. It's a relief when that burnt feeling subsides after several days. But imagine experiencing that burning sensation all day, every day.

7 May 2011

H. pylori DNA may help treat severe colitis

DNA from Helicobacter pylori, a common stomach bacteria, minimizes the effects of colitis in mice, according to a new study by University of Michigan Medical School scientists.

6 May 2011

Survey: Only 12% of black stroke patients call 9-1-1 after experiencing symptoms

Most African-Americans say they'd call 9-1-1 if stroke symptoms occurred — but few do, according to research reported in Stroke: Journal of the American Heart Association.

6 May 2011

Millennium presents three studies in relapsed multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported results from three studies in relapsed multiple myeloma. Two of the studies examined the use of VELCADE for Injection; the third study presents clinical data on MLN9708, the first investigational oral proteasome inhibitor.

6 May 2011

Kaiser Permanente awards $7.7 million as 217 grants during first quarter, 2011

Kaiser Permanente, one of the country's largest not-for-profit health care organizations, announced today that it has funded 217 grants nationwide, totaling approximately $7.7 million in the first quarter of 2011.

6 May 2011

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL™ will be presented at two medical meetings.

6 May 2011

Surgeon turns inventor to improve recovery from rotator cuff injury

A South Wales surgeon has turned inventor with the help of a leading medical manufacturer and his surgical device is set to be used in operating theatres across the UK and the world in repairing massive tears of the shoulder’s rotator cuff previously regarded as irreparable.

5 May 2011

Fecal transplant procedures performed at Sinai Hospital

Sudhir Dutta, M.D., head of the Division of Gastroenterology at Sinai Hospital, performed fecal transplant procedures for two patients with severe clostridium difficile (C. difficile) colitis that did not respond to routine antibiotic and other treatments. C. difficile causes symptoms ranging from mild diarrhea to more serious, sometimes life threatening colon inflammation.

5 May 2011

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Pfizer Inc. announced that Revatio (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17 years old with pulmonary arterial hypertension. Efficacy in terms of improvement of exercise capacity or pulmonary hemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.

5 May 2011

Mylan launches Oxycodone and Aspirin Tablets for treatment of severe pain

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.

5 May 2011

FDA releases final guidance to firms that market OTC drug products

The U.S. Food and Drug Administration today released its final guidance to firms that manufacture, market, or distribute over-the-counter liquid drug products packaged with cups, droppers, syringes, and spoons to measure and dispense the doses of medication.

5 May 2011